A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem

NCT05106153 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Non-dependent, Recreational Sedative Users
Abuse Potential

Interventions

DRUG: Suvorexant
DRUG: Zolpidem
DRUG: Seltorexant
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC